Opportunity Information: Apply for RFA HD 23 021

The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) funding opportunity (RFA HD 23 021) is a National Institutes of Health cooperative agreement designed to strengthen the national research infrastructure that supports HIV prevention and treatment studies focused on adolescents and young adults. The core idea is to fund an operations-and-collaboration hub for the ATN, helping the broader network consistently design, launch, and run high-quality studies that address urgent public health needs for youth ages 13 to 24 who are either at risk for HIV or living with HIV. A central emphasis is the meaningful inclusion of minors, reflecting the reality that many prevention and care challenges begin before adulthood and that evidence-based interventions often need to be tested with younger participants to be truly applicable.

Through this program, the ATN is expected to have the capacity to develop and conduct a wide range of trial types, not limited to a single approach. The FOA specifically highlights innovative behavioral interventions, community-based studies, translational work that helps move discoveries into real-world practice, and biomedical trials that can include therapeutic strategies as well as microbicide and vaccine studies. In plain terms, the opportunity is aimed at supporting a coordinated platform where researchers can test what actually works for youth in different settings, including clinics and community environments, and where studies can be executed with the rigor needed for results to influence clinical guidelines and public health programs.

Because this is a cooperative agreement rather than a standard grant, applicants should expect substantial involvement from NIH in the funded work. Cooperative agreements typically mean the funder is not just providing money but is also an active partner in shaping priorities, ensuring coordination, and maintaining performance expectations across the network. The goal is to keep research operations aligned, reduce duplication, and accelerate the pace at which promising interventions can be evaluated and, when effective, scaled.

The FOA encourages applications from investigators who bring fresh thinking and novel approaches to adolescent HIV challenges. Eligibility is broad across U.S.-based organizations and reflects a desire to include entities with strong connections to affected communities and youth-serving systems. Eligible applicants include state, county, city or township governments, special district governments, and independent school districts, along with public and state-controlled institutions of higher education and private institutions of higher education. It also includes Native American tribal governments (federally recognized) and Native American tribal organizations (other than federally recognized tribal governments), public housing authorities/Indian housing authorities, nonprofits with or without 501(c)(3) status, for-profit organizations (other than small businesses), and small businesses, as well as other organizations that meet NIH requirements. The announcement also explicitly calls out a variety of institution types as encouraged participants, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations and eligible federal agencies. This broad eligibility signals a strong interest in diverse partnerships and research that is grounded in the lived realities of the populations most impacted.

At the same time, there are clear geographic and organizational limits related to foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply, non-domestic components of U.S. organizations are not eligible to apply, and foreign components as defined in the NIH Grants Policy Statement are not allowed. In practice, this means the work must be led and carried out within allowable U.S.-based organizational structures, without foreign components embedded in the project.

Administratively, this opportunity is categorized as discretionary funding using the cooperative agreement mechanism, and it sits within federal activity categories tied to education, health, income security, and social services. The CFDA numbers listed for this opportunity are 93.242, 93.279, and 93.865. The original closing date shown is March 31, 2022, and the listed award ceiling is $6,250,000. The FOA creation date is December 1, 2021. While the summary information provided does not specify the exact number of expected awards, the ceiling indicates a large, centralized award consistent with a network operations and coordination function rather than a small single-project research grant.

Overall, the opportunity is about building and maintaining the operational backbone and collaborative capacity of the ATN so that the network can reliably deliver innovative, youth-focused HIV intervention trials. It prioritizes rigorous research that is inclusive of minors, supports a broad range of intervention types from behavioral to biomedical, and encourages participation from a wide array of U.S. institutions and community-connected organizations positioned to reach adolescents and young adults most affected by HIV.

  • The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.279, 93.865.
  • This funding opportunity was created on 2021-12-01.
  • Applicants must submit their applications by 2022-03-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $6,250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA HD 23 021

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This opportunity is the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) funding opportunity, referenced as RFA HD 23 021. It is a National Institutes of Health (NIH) cooperative agreement intended to support the national research infrastructure behind HIV prevention and treatment studies for adolescents and young adults.

What is the main goal of the award?

The main goal is to fund an operations-and-collaboration hub for the ATN so the network can consistently design, launch, and run high-quality studies that address urgent public health needs for youth ages 13 to 24 who are at risk for HIV or living with HIV.

What does "Operations and Collaborations Center" mean in practice?

Based on the description provided, the center functions as the operational backbone and collaboration hub for the broader ATN. The intent is to improve coordination, maintain consistent research quality, reduce duplication across the network, and help promising interventions move faster from evaluation to broader use when they work.

Who is the target population for the research supported by this program?

The research focus is on adolescents and young adults ages 13 to 24, specifically youth who are either at risk for HIV or living with HIV.

Does this opportunity emphasize inclusion of minors?

Yes. A central emphasis is the meaningful inclusion of minors. The rationale described is that many prevention and care challenges begin before adulthood, and interventions often need to be tested with younger participants to ensure the evidence is truly applicable.

What kinds of studies or trials are expected to be supported through this funding?

The program is expected to support a wide range of trial types, not limited to a single approach. The information provided highlights innovative behavioral interventions, community-based studies, translational work that moves discoveries into real-world practice, and biomedical trials. Biomedical trials may include therapeutic strategies as well as microbicide and vaccine studies.

Is this award limited to clinic-based research only?

No. The description indicates the platform is intended to support research in different settings, including clinics and community environments.

What does "UM2 Clinical Trial Optional" imply?

The opportunity is labeled "UM2 Clinical Trial Optional," and the summary emphasizes that the ATN should have capacity to develop and conduct a broad range of trial types. The provided information does not describe additional administrative requirements tied to the "clinical trial optional" designation beyond that framing.

What type of funding mechanism is this?

This is a cooperative agreement, not a standard grant. The program is described as discretionary funding using the cooperative agreement mechanism.

How is a cooperative agreement different from a standard grant in this context?

The description states that cooperative agreements typically involve substantial involvement from NIH in the funded work. NIH is described as an active partner that helps shape priorities, ensure coordination, and maintain performance expectations across the network.

Why does NIH involvement matter for applicants?

Applicants should expect closer coordination with NIH than under a standard grant. The purpose described is to keep research operations aligned, reduce duplication, and accelerate evaluation and potential scaling of effective interventions.

What organizations are eligible to apply?

Eligibility is broad across U.S.-based organizations. Eligible applicants include: state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); Native American tribal organizations (other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); small businesses; and other organizations that meet NIH requirements.

Are specific institution types encouraged to participate?

Yes. The announcement explicitly encourages participation from institution types including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, eligible federal agencies, and other community-connected entities.

Can foreign (non-U.S.) organizations apply?

No. Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply.

Can a U.S. organization include a non-U.S. component in the project?

No. The summary states that non-domestic components of U.S. organizations are not eligible to apply and that foreign components (as defined in the NIH Grants Policy Statement) are not allowed.

What is the practical meaning of the foreign involvement restrictions?

As described, the work must be led and carried out within allowable U.S.-based organizational structures and cannot include foreign components embedded in the project.

What is the award ceiling for this opportunity?

The listed award ceiling is $6,250,000.

Does the opportunity indicate how many awards will be made?

The summary information provided does not specify the exact number of expected awards. It notes that the ceiling suggests a large, centralized award consistent with a network operations and coordination function.

When was this funding opportunity created?

The FOA creation date is December 1, 2021.

What is the closing date shown for the opportunity?

The original closing date shown is March 31, 2022.

Which federal activity categories are associated with this opportunity?

The opportunity is described as sitting within federal activity categories tied to education, health, income security, and social services.

What CFDA numbers are associated with this funding opportunity?

The CFDA numbers listed are 93.242, 93.279, and 93.865.

What kinds of research priorities does the FOA highlight?

The FOA highlights innovative approaches to adolescent HIV challenges, with specific mention of behavioral interventions, community-based work, translational efforts to move discoveries into practice, and biomedical research including therapeutic strategies, microbicide studies, and vaccine studies.

What is the overall purpose of building this ATN hub?

The overall purpose is to build and maintain the operational backbone and collaborative capacity of the ATN so the network can reliably deliver rigorous, youth-focused HIV intervention trials that can influence clinical guidelines and public health programs when successful.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health, Income Security and Social Services

Next opportunity: ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed)

Previous opportunity: NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA HD 23 021

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA HD 23 021) also looked into and applied for these:

Funding Opportunity
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center (UM2 Clinical Trial Optional) Apply for RFA HD 23 020

Funding Number: RFA HD 23 020
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: $6,875,000
BRAIN Initiative-Related Research Education: Short Courses (R25 Clinical Trial Not Allowed) Apply for RFA EY 21 003

Funding Number: RFA EY 21 003
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: $250,000
HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed) Apply for RFA NS 22 045

Funding Number: RFA NS 22 045
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) Apply for PAR 21 357

Funding Number: PAR 21 357
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: $300,000
HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required) Apply for RFA NS 22 037

Funding Number: RFA NS 22 037
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 145

Funding Number: RFA MH 22 145
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) Apply for RFA DE 22 011

Funding Number: RFA DE 22 011
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) Apply for RFA MH 22 176

Funding Number: RFA MH 22 176
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: $500,000
Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) Apply for RFA MH 22 175

Funding Number: RFA MH 22 175
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: $12,500,000
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) Apply for RFA MH 22 115

Funding Number: RFA MH 22 115
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required) Apply for RFA NR 22 002

Funding Number: RFA NR 22 002
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional) Apply for RFA NR 22 003

Funding Number: RFA NR 22 003
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: $275,000
HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 021

Funding Number: RFA NS 22 021
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) Apply for RFA NS 22 050

Funding Number: RFA NS 22 050
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) Apply for RFA NS 22 026

Funding Number: RFA NS 22 026
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) Apply for RFA NS 22 027

Funding Number: RFA NS 22 027
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: $225,000
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Mouse Brain (UM1 Clinical Trial Not Allowed) Apply for RFA NS 22 048

Funding Number: RFA NS 22 048
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 049

Funding Number: RFA NS 22 049
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Comprehensive Centers for Human and Non-Human Primate Brain (UM1 Clinical Trial Not Allowed) Apply for RFA NS 22 047

Funding Number: RFA NS 22 047
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent
BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) Apply for RFA NS 22 028

Funding Number: RFA NS 22 028
Agency: National Institutes of Health
Category: Education, Health, Income Security and Social Services
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 23 021", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: